drugset / Trial / NCT06998004
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults
RandomizedSequentialQuadruple-blindPrevention
Summary
The purpose of this first time in humans trial is to evaluate the safety, reactogenicity and immunogenicity of AVX70120 and of AVX70481 in healthy participants.
Timeline
- Start
- 2024-06-16
- Primary completion
- 2026-01-26
- Completion
- 2026-01-26